Clinical Edge

Summaries of Must-Read Clinical Literature, Guidelines, and FDA Actions

Study links GLP-1R agonists, lower inflammatory biomarker levels

Key clinical point: Glucagonlike peptide receptor–1 (GLP-1R) agonists may lower periostin levels in asthma.

Major finding: Counts were 30% lower in GLP-1R agonists versus non-GLP-1R agonist groups.

Study details: A retrospective evaluation of serum samples of 163 adults with asthma and type 2 diabetes.

Disclosures: Dr. Foer has no financial relationships to disclose.

Citation:

Foer D et al. AAAAI Session 462, Abstract 784.